Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 529

Similar articles for PubMed (Select 15590768)


High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.

Peng JH, Fryer JD, Hurst RS, Schroeder KM, George AA, Morrissy S, Groppi VE, Leonard SS, Lukas RJ.

J Pharmacol Exp Ther. 2005 Apr;313(1):24-35. Epub 2004 Dec 8.


Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells.

Eaton JB, Peng JH, Schroeder KM, George AA, Fryer JD, Krishnan C, Buhlman L, Kuo YP, Steinlein O, Lukas RJ.

Mol Pharmacol. 2003 Dec;64(6):1283-94. Erratum in: Mol Pharmacol. 2004 Jul;66(1):197.


Inducible, heterologous expression of human alpha7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line.

Peng JH, Lucero L, Fryer J, Herl J, Leonard SS, Lukas RJ.

Brain Res. 1999 Apr 17;825(1-2):172-9.


Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line.

Zhao L, Kuo YP, George AA, Peng JH, Purandare MS, Schroeder KM, Lukas RJ, Wu J.

J Pharmacol Exp Ther. 2003 Jun;305(3):1132-41. Epub 2003 Mar 6.


Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites.

Quik M, Choremis J, Komourian J, Lukas RJ, Puchacz E.

J Neurochem. 1996 Jul;67(1):145-54.


beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells.

Wu J, Kuo YP, George AA, Xu L, Hu J, Lukas RJ.

J Biol Chem. 2004 Sep 3;279(36):37842-51. Epub 2004 Jul 2.


Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-halpha7 cells by activating neuronal nicotinic acetylcholine receptors.

Pakkanen JS, Nousiainen H, Yli-Kauhaluoma J, Kylänlahti I, Möykkynen T, Korpi ER, Peng JH, Lukas RJ, Ahtee L, Tuominen RK.

J Neurochem. 2005 Sep;94(5):1329-41. Epub 2005 Jul 5.


ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.

Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP.

J Pharmacol Exp Ther. 1998 May;285(2):777-86.


Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.

Wu J, Liu Q, Yu K, Hu J, Kuo YP, Segerberg M, St John PA, Lukas RJ.

J Physiol. 2006 Oct 1;576(Pt 1):103-18. Epub 2006 Jul 6.


Heterologous expression of human {alpha}6{beta}4{beta}3{alpha}5 nicotinic acetylcholine receptors: binding properties consistent with their natural expression require quaternary subunit assembly including the {alpha}5 subunit.

Grinevich VP, Letchworth SR, Lindenberger KA, Menager J, Mary V, Sadieva KA, Buhlman LM, Bohme GA, Pradier L, Benavides J, Lukas RJ, Bencherif M.

J Pharmacol Exp Ther. 2005 Feb;312(2):619-26. Epub 2004 Sep 8.


Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.

Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C.

Br J Pharmacol. 2005 Dec;146(8):1096-109.


Iptakalim as a human nicotinic acetylcholine receptor antagonist.

Hu J, Lindenberger K, Hu G, Wang H, Lukas RJ, Wu J.

J Pharmacol Exp Ther. 2006 Feb;316(2):914-25. Epub 2005 Oct 13.


Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro.

Deuther-Conrad W, Patt JT, Feuerbach D, Wegner F, Brust P, Steinbach J.

Farmaco. 2004 Oct;59(10):785-92.


[3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.

Anderson DJ, Bunnelle W, Surber B, Du J, Surowy C, Tribollet E, Marguerat A, Bertrand D, Gopalakrishnan M.

J Pharmacol Exp Ther. 2008 Jan;324(1):179-87. Epub 2007 Oct 24.


U18666A, a cholesterol-inhibition agent, modulates human neuronal nicotinic acetylcholine receptors heterologously expressed in SH-EP1 cell line.

Zheng C, Wang MY, Liu Q, Wakui M, Whiteaker P, Lukas RJ, Wu J.

J Neurochem. 2009 Mar;108(6):1526-38. doi: 10.1111/j.1471-4159.2009.05903.x. Epub 2009 Feb 16.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk